Friday, June 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 175 of 1,261

  1. US 11730794

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  2. US 11730801

    Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof

    The Board of Regents of the University of Texas System · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  3. US 11730802

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  4. US 11730793

    Sustained release formulations using non-aqueous emulsions

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  5. US 11730741

    6-chromanol derivatives for use as a medicament

    Sulfateq B.V. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  6. US 11730709

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  7. US 11730717

    Melanin-inspired antimicrobial

    THE BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  8. US 11730720

    ALK5 inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  9. US 11730723

    Compounds and methods for treating viral infections

    LEXICON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  10. US 11730705

    Small molecule CMKLR1 antagonists in inflammatory disease

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  11. US 11732024

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  12. US 11730820

    Peptidic blocks for nucleic acid delivery

    S. M. DISCOVERY GROUP INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  13. US 11731968

    Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  14. US 11731976

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  15. US 11732025

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  16. US 11731953

    Methods and compounds for restoring mutant p53 function

    PMV PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  17. US 11731986

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  18. US 11732005

    Peptidomimetic proteasome inhibitors

    Tri-Institutional Therapeutics Discovery Institute, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  19. US 11732007

    Therapeutic compounds and methods

    The Regents of the University of California · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  20. US 11732037

    Weight loss regimen

    Boards of Regents, The University of Texas System · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  21. US 11732041

    Antibodies against 4G7-derived chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  22. US 11733191

    Closed-loop controlled chemical apparatus

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  23. US 11732265

    Compositions and methods for modulating complement factor B expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  24. US 11731977

    SGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.